Haptena Therapeutics

Seed
haptena.com Biotech & Healthcare
Total Funding $3.5M
Latest Round $3.5M Seed
Last Announced Dec 16, 2025
Investors Undisclosed
Decision Makers Profile Active

About Haptena Therapeutics

Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering. Our research focuses on KRAS-mutant tumors to deliver more effective and durable treatment options.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website haptena.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $3,530,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Haptena Therapeutics.

Funding History

1 Round
Seed equity · Dec 16, 2025

Founders & Leadership

2

Chiara Ambrogio

Co-Founder

Work email & phone locked Unlock →

Roberto Chiarle

Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts